Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Conflicting studies on besipirdine

June 21, 1996

Colchicine/hydroxychloroquine therapy of AD

June 14, 1996

Aspartate derivative with antiamnestic activity synthesized

June 14, 1996

More possible Alzheimer's treatment

June 14, 1996

XSB-1E as possible Alzheimer's treatment

June 14, 1996

MF-8622 undergoes preclinical evaluation

June 14, 1996

NN-42-1007: First potent and selective hepatic glycogen phosphorylase inhibitor

June 7, 1996

Ongoing evaluation of Pharmacia & Upjohn's new water-soluble camptothecin derivative

June 7, 1996

A7-183: Effective topical therapy of recurrent herpes labialis and genitalis

June 7, 1996

Protein farnesyltransferase inhibitor from Banyu and Merck & Co.

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.